June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
3 months kinetics of Type 1 Diabetes model in Brown Norway rats : Retinal phenotypes and molecular analysis
Author Affiliations & Notes
  • Provost Alexandra
    Sanofi Ophtalmology, Sanofi, Paris, France
  • Brahim El Mathari
    Sanofi Ophtalmology, Sanofi, Paris, France
  • Alexandra Trehin
    Sanofi Ophtalmology, Sanofi, Paris, France
  • Carine Bernard
    Sanofi Ophtalmology, Sanofi, Paris, France
  • Damien Lavier
    Sanofi Ophtalmology, Sanofi, Paris, France
  • Annabelle Amiard
    Sanofi Ophtalmology, Sanofi, Paris, France
  • Manuel SIMONUTTI
    Institut de la Vision, Paris, France
  • Anais Potey
    Institut de la Vision, Paris, France
  • Samantha Beck
    Institut de la Vision, Paris, France
  • Thomas Debeir
    Sanofi Ophtalmology, Sanofi, Paris, France
  • Footnotes
    Commercial Relationships Provost Alexandra, Sanofi (E); Brahim El Mathari, Sanofi (E); Alexandra Trehin, Sanofi (E); Carine Bernard, Sanofi (E); Damien Lavier, Sanofi (E); Annabelle Amiard, Sanofi (E); Manuel SIMONUTTI, Sanofi (C); Anais Potey, Sanofi (C); Samantha Beck, Sanofi (C); Thomas Debeir, Sanofi (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5182. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Provost Alexandra, Brahim El Mathari, Alexandra Trehin, Carine Bernard, Damien Lavier, Annabelle Amiard, Manuel SIMONUTTI, Anais Potey, Samantha Beck, Thomas Debeir; 3 months kinetics of Type 1 Diabetes model in Brown Norway rats : Retinal phenotypes and molecular analysis. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5182.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Diabetes is associated with retinal microvascular changes that include leakage and leukostatis, leading to diabetic retinopathy. We investigated the Brown Norway rat during a 3 month period, after induction of diabetes by streptozotocin (STZ), to determine if this pigmented strain develops early-stage diabetic retinopathy.

Methods: Diabetes was induced in Brown Norway rats with a single IP injection of streptozotocin (65mg/kg). Diabetic and non-diabetic animals were examined over a period of 3 months to monitor changes in retinal vascular pathology using in vivo fluorescein angiography, functional alterations using electroretinography (ERG), and modifications in blood-retinal barrier permeability using blue Evans perfusion. Further, loss of pericytes and acellular capillaries was caracterized by periodic acid shiff staining (PAS), Adhesion of leukocytes at the retinal vessels was assessed by concanavaline A staining, and neuro-inflammation was explored by Quantitative PCR and immunohistochemistry of retinal sections.

Results: 3 months after induction of diabetes in the Brown Norway rats, the PAS and retinal permeability analysis showed no evidence of vascular and morphological changes such as degenerated capillaries and pericytes ghosts. Fluorescein angiography was difficult to analyse because of diabetes induced lens opacification. However, at ERG, there was impairment of dark-adapted a and b-wave latency, but without modification of dark-adapted a and b-wave amplitude, in the diabetic rats. Further, inflammatory markers such as GFAP and IBA1 were more expressed on retinal sections under diabetic conditions versus controls, especially in the ganglionic cell layer. Finally, molecular analysis showed an increased expression of inflammatory genes in the retina of diabetic rats (GFAP, CXCL9-10-11), and the retinal leukostasis assay demonstrated an increase of leukocyte adherence to the retinal vasculature as compared to controls.

Conclusions: Over the 3 month period following induction of diabetes, the Brown Norway rats did not present with a diabetic retinopathy characterized by degeneration of retinal capillaries but showed early neuro-inflammation and alteration of visual function.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×